Allergen Immunotherapy or Omalizumab in Asthma: When to Use Which?
Friday, February 28, 2014: 5:15 PM-6:15 PM
Marriott South Tower, Level 3, Balboa
1.00 CME/ 1.20 CE
Primary Discussion Leaders:
Thomas B. Casale , MD FAAAAI
Jonathan Corren , MD
Learning Objectives:
  1. Review efficacy of IT in asthma and safety of AIT in moderate-severe asthma
  2. Review studies of omalizumab alone and in combination with AIT in asthma
  3. Make recommendations on individual use of these drugs and in combination for asthma
  • Session 1901 handout.pdf (438.6 kB)
  • See more of: Seminar